Trials / Completed
CompletedNCT00500227
Predictive Factors of Response to Somatostatin Analogues in Acromegalic Patients With Persistent Disease Following Surgery
Observational Study to Evaluate, in Acromegalic Patients With Disease Persistence After Surgery, Those Histopathologic, Clinical, Morphologic and Biochemical Factors Predictors of Hormonal Control Under Somatostatin Analogue Treatment
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 55 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate, in acromegalic patients with disease persistence after surgery who are treated with somatostatin analogues, the histopathological, clinical, morphological and biochemical factors which are predictive of hormonal control.
Conditions
Timeline
- Start date
- 2007-09-01
- Primary completion
- 2012-07-01
- Completion
- 2012-07-01
- First posted
- 2007-07-12
- Last updated
- 2019-01-14
Locations
30 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT00500227. Inclusion in this directory is not an endorsement.